Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):397-9. doi: 10.1097/qai.0b013e31815b0d35.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • Canada
  • Drug Resistance, Viral / genetics*
  • Female
  • Genotype
  • HIV / drug effects
  • HIV / genetics
  • HIV Infections / blood
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • Humans
  • Longitudinal Studies
  • Male
  • Methadone / therapeutic use
  • Middle Aged
  • Models, Theoretical
  • Mutation*
  • Patient Compliance / statistics & numerical data*
  • RNA, Viral / blood
  • RNA, Viral / genetics
  • Retrospective Studies
  • Viral Load

Substances

  • RNA, Viral
  • Methadone